During this initial rollout, Tyber Medical will make the new cannulated trauma screw system available to select private label partners and surgeon advisors.

"The highlight of the trauma screw implant is the optimized thread design. Our implants are designed to deliver enhanced compression and pullout resistance in both cortical and cancellous bone. The self-cutting and self-countersinking flutes ensure a clean approach during implantation. The implants are complimented by a full array of cannulated instruments designed for ease of use," said Tyber Medical Project Leader, Chris Faresich.

Tyber Medical plans to undergo a full product launch in late Q4 of this year and is currently looking for new private label partners interested in branding these differentiated products.

"We are happy to provide an effective alternative to the prevailing methods of doing business in the medical device industry. Our private label business model offers companies access to portfolio enhancing, regulatory approved implants in a matter of months.

Tyber Medical has developed comprehensive processes that allow companies to conserve internal resources and increase profitability immediately," said Tyber Medical Sales Manager, Stu Shank.

Tyber Medical Representatives will be attending both the 2014 annual meeting of the American Society for Surgery of the Hand (ASSH) in Boston, MA from September 18-20, as well as, the 2014 annual meeting of the American Orthopaedic Foot & Ankle Society (AOFAS) in Chicago, IL from September 21-23.